3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Jacobs syndrome
1
Gastrointestinal Neoplasms
1
Interventions
Specimen Handling
219
Magnetic Resonance Spectroscopy
196
pembrolizumab
195
Carboplatin
169
Cisplatin
137
Biopsy
130
Nivolumab
127
Paclitaxel
112
Cyclophosphamide
109
Radiotherapy
104
Gemcitabine
103
durvalumab
88
Dexamethasone
88
atezolizumab
75
Rituximab
69
Radiation
67
Lenalidomide
67
Pemetrexed
65
Doxorubicin
64
Bevacizumab
64
Docetaxel
61
Etoposide
57
Ipilimumab
56
olaparib
54
Fluorouracil
50
Prednisone
49
Oxaliplatin
49
venetoclax
48
Taxes
48
Radiosurgery
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
avatrombopag
×
90 days
×
Clear all
NCT05772546
2026-03-13
ACT-GI
Massachusetts General Hospital
Phase 2
Active not recruiting
60 enrolled